Brain Plasticity in Autism- new approaches from Yale University

UPDATE: This event has been postponed for Spring 2021. Please revisit this page again or subscribe to our mailing list for future announcements

A day with Harry Schneider, MD PhD, Yale University: Improving Neurological, Linguistic and Motor Challenges in ASD

All brains are able to change by forming new neural connections. This ability to change is known neuroplasticity or brain plasticity. The capacity of the brain to, under the right circumstances, re-organize itself physically and functionally underpins trans-cranial Direct Current stimulation (tDCS) as a treatment modality.

Thinking Autism is proud to present a one day conference with Harry D. Schneider PhD, MD, MPH, Consultant in Neurolinguistics to the Joy Hirsch PhD, Director of Brain Function Laboratory, Yale University School of Medicine, who will share his decades of research and clinical experience of tDCS.

Trans-cranial Direct Current Stimulation is a treatment modality with an excellent safety record which focuses on improving brain plasticity. TDCS is accepted at institutions of higher learning and hospitals all over the world. It is FDA-cleared in the US and successfully used for treating depression, anxiety, brain trauma—including loss of language—and many other disorders.

The research on its potential for reducing difficulties and symptoms associated with autism has been accumulating in recent years. Read more here.

Event outline

In the morning session Dr Schneider will outline the foundations of tDCS: how it works, the body of research behind it, what is its status and acceptance with FDA and the safety profile. The afternoon session will consist of a hands-on demonstration, followed by a question & answer session.

Tickets

Tickets £20, free to Thinking Autism members. Light lunch included.
Members will need to book a ticket and will receive a full refund after attending the event. Cancellations of less than 48 before the event and no-shows will not receive a refund